People · Operator
Named in public records as an officer, director or promoter · active 2014–2017 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Can-Fite BioPharma Ltd. | — | Pharmaceuticals | Series A | $82.2M | $160.3M | 2014 |
Gil Oren at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Gil Oren on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Yechezkel Barenholz | 1 | 3 |
| Yaacov Goldman | 1 | 3 |
| Guy Regev | 1 | 1 |
| Pnina Fishman | 1 | 1 |
| Motti Farbstein | 1 | 1 |
| Ilan Cohn | 1 | 1 |
| Barak Singer | 1 | 1 |
| Abraham Sartani | 1 | 1 |
| Yossi Bornstein | 1 | 1 |
| Yoseph Borenstein | 1 | 1 |
| Israel Shamay | 1 | 1 |
| Golan Bitton | 1 | 1 |
| Abraham Sartini | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.